Cross-Reactivity of Three Recombinant Insulin Analogs with Five Commercial Insulin Immunoassays
Authors:
- 1 January 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 50 (1) , 257-259
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Use of a Novel Double-Antibody Technique to Describe the Pharmacokinetics of Rapid-Acting Insulin AnalogsDiabetes Care, 2002
- A sensitive chemiluminescent enzyme immunoassay for the bioanalysis of carboxyl-terminal B-chain analogues of human insulinJournal of Pharmaceutical and Biomedical Analysis, 2001
- Elecsys Insulin Assay: Free Insulin Determination and the Absence of Cross-Reactivity with Insulin LisproClinical Chemistry, 2001
- A New Insulin Immunoassay Specific for the Rapid-Acting Insulin Analog, Insulin Aspart, Suitable for Bioavailability, Bioequivalence, and Pharmacokinetic StudiesClinical Biochemistry, 2000
- Sensitive RIA for the Specific Determination of Insulin LisproClinical Chemistry, 1999
- Validity of Coat-A-Count insulin RIA kit for quantifying total and free humalogClinical Chemistry, 1996
- Humalog, a rapidly absorbed analog of human insulin, determined with Coat-A-Count insulin radioimmunoassayClinical Chemistry, 1995